Summary
This prediction ended on 10.03.24 with a price of €9.67. The price of Altimmune has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.02%. HC_Wainwright has a follow-up prediction for Altimmune where he still thinks Altimmune is a Buy. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Altimmune | -3.181% | -3.181% | -29.827% | -10.148% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % | 52,00 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % | 77,54 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % | 64,68 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % | 63,01 % |
Comments by HC_Wainwright for this prediction
In the thread Altimmune diskutieren
Altimmune, Inc. (NASDAQ: ALT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Ratings data for ALT provided by MarketBeat
In the thread Trading Altimmune
Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten